Clinical Study to Determine if Ecopipam Can Reduce Urges to Gamble

PHASE2CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

May 31, 2012

Study Completion Date

August 31, 2012

Conditions
Pathological Gambling
Interventions
DRUG

Ecopipam

50mg tablets

Trial Locations (4)

52242

Carver College of Medicine, University of Iowa, Iowa City

55454

University of Minnesota School of Medicine, Minneapolis

90095

University of California, Los Angeles, Los Angeles

06519

Yale University, New Haven

Sponsors
All Listed Sponsors
collaborator

Psyadon Pharma

INDUSTRY

lead

Emalex Biosciences Inc.

INDUSTRY